Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yamashita Health Care HoldingsTSE:9265 -2.02%64 Return-on-Tangible-Equity is 14.37% as of Feb. 2026, which is 98% above its 10-year median of 7.25. GuruFocus rates TSE:9265 with a GF Score™ of 64/100 and a GF Value™ of 円2,955.01 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 111 Medical Distribution companies, Yamashita Health Care Holdings ranks worse than 57.66% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Yamashita Health Care Holdings's annualized net income for the quarter that ended in Feb. 2026 was 円1,228 Mil. Yamashita Health Care Holdings's average shareholder tangible equity for the quarter that ended in Feb. 2026 was 円8,544 Mil. Therefore, Yamashita Health Care Holdings's annualized Return-on-Tangible-Equity for the quarter that ended in Feb. 2026 was 14.37%.
The historical rank and industry rank for Yamashita Health Care Holdings's Return-on-Tangible-Equity or its related term are showing as below:
TSE:9265'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 2.4 Med: 7.25 Max: 9.54
Current: 7.48
During the past 9 years, Yamashita Health Care Holdings's highest Return-on-Tangible-Equity was 9.54%. The lowest was 2.40%. And the median was 7.25%.
TSE:9265's Return-on-Tangible-Equity is ranked worse than 57.66% of 111
companies
in the Medical Distribution industry
Industry Median: 8.78
vs TSE:9265: 7.48
Yamashita Health Care Holdings (TSE:9265) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Yamashita Health Care Holdings Return-on-Tangible-Equity Related Terms
Yamashita Health Care Holdings Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yamashita Health Care Holdings Return-on-Tangible-Equity Chart
TSE:9265 vs MCK, COR, CAH: Return-on-Tangible-Equity Comparison
For the Medical Distribution subindustry, Yamashita Health Care Holdings's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yamashita Health Care Holdings Return-on-Tangible-Equity vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Yamashita Health Care Holdings's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Yamashita Health Care Holdings's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Feb. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 14.37% mean?
Yamashita Health Care Holdings (TSE:9265) has a Return-on-Tangible-Equity of 14.37% as of Feb. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Yamashita Health Care Holdings and its competitors. This is 98% above median its historical median of 7.25. Over the past decade, Yamashita Health Care Holdings' Return-on-Tangible-Equity has ranged from 2.40 to 9.54. According to the industry distribution chart, Yamashita Health Care Holdings ranks #64 out of 111 companies in the Medical Distribution industry, placing it in the top 57.7%.
Is Yamashita Health Care Holdings' Return-on-Tangible-Equity too high?
Yamashita Health Care Holdings' current Return-on-Tangible-Equity of 14.37% is 98% above median its 10-year median of 7.25. Over the past 10 years, this metric has ranged from a low of 2.40 to a high of 9.54. The Medical Distribution industry median Return-on-Tangible-Equity is 8.78. Yamashita Health Care Holdings' value of 14.37% is 63.7% above this industry median. Based on the distribution chart, Yamashita Health Care Holdings ranks #64 out of 111 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Yamashita Health Care Holdings has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Yamashita Health Care Holdings' Return-on-Tangible-Equity compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Yamashita Health Care Holdings ranks #64 out of 111 companies for Return-on-Tangible-Equity. This places Yamashita Health Care Holdings in the lower half of its industry. The industry median Return-on-Tangible-Equity is 8.78. Yamashita Health Care Holdings' value of 14.37% is 63.7% above this benchmark. Historically, Yamashita Health Care Holdings' own Return-on-Tangible-Equity has ranged from 2.40 to 9.54 over the past decade. While the company's 10-year median is 7.25 vs. the industry median of 8.78, Yamashita Health Care Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Distribution company?
The median Return-on-Tangible-Equity among Medical Distribution companies is 8.78, based on 111 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yamashita Health Care Holdings's current Return-on-Tangible-Equity of 14.37% is 63.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Yamashita Health Care Holdings and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Equity is 8.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yamashita Health Care Holdings's current Return-on-Tangible-Equity is 14.37%, which is 98% above median its own 10-year median of 7.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yamashita Health Care Holdings stock overvalued right now?
Based on GuruFocus' analysis, Yamashita Health Care Holdings (TSE:9265) is currently considered Modestly Overvalued. The stock's GF Value™ is 円2,955.01, compared to a current price of 円3,395.00 — trading 14.9% above its estimated fair value. The current Return-on-Tangible-Equity is 14.37%, which is 98% above median its 10-year median of 7.25 and 63.7% above the Medical Distribution industry median of 8.78. Yamashita Health Care Holdings' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Yamashita Health Care Holdings (TSE:9265), the current Return-on-Tangible-Equity is 14.37% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yamashita Health Care Holdings (TSE:9265) Overvalued in 2026?
Based on GuruFocus' analysis, Yamashita Health Care Holdings stock appears to be overvalued.
The current stock price of 円3,395.00 is trading 14.9% above its estimated GF Value™ of 円2,955.01.
GuruFocus considers Yamashita Health Care Holdings to be Modestly Overvalued.
Key valuation signals for TSE:9265:
Return-on-Tangible-Equity: 14.37% (98% above median its 10-year median of 7.25)
GF Value™: 円2,955.01 vs. price of 円3,395.00 (14.9% above fair value)
Industry Position: 63.7% above the Medical Distribution median (#64 of 111)
No single metric tells the full story. See the TSE:9265 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yamashita Health Care Holdings Inc is a Japan-based medical equipment wholesale company that sells medical equipment for medical institutions within the Kyushu area. The company is also engaged in the manufacture, sale, leasing, and rental of optical instruments, physicochemical instruments, analytical instruments, measuring instruments, health equipment, exercise equipment, nursing care equipment, animal medical equipment, and veterinary drugs.
64GF Score
Get the complete analysis for TSE:9265
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9265 has been successfully added to your 
